CTRI Number |
CTRI/2020/08/027498 [Registered on: 31/08/2020] Trial Registered Prospectively |
Last Modified On: |
28/08/2020 |
Post Graduate Thesis |
No |
Type of Trial |
Observational |
Type of Study
|
Cross Sectional Study |
Study Design |
Other |
Public Title of Study
|
Impact of heavy metals on unexplained preterm birth and related death |
Scientific Title of Study
|
Unexplained preterm birth and related death:Does heavy metals play heavily |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Dinesh Upadhya |
Designation |
Associate Professor and Coordinator |
Affiliation |
Manipal Academy of Higher Education |
Address |
Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104
Udupi KARNATAKA 576104 India |
Phone |
8747012060 |
Fax |
|
Email |
dinesh.upadhya@manipal.edu |
|
Details of Contact Person Scientific Query
|
Name |
Dr Dinesh Upadhya |
Designation |
Associate Professor and Coordinator |
Affiliation |
Manipal Academy of Higher Education |
Address |
Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104
Udupi KARNATAKA 576104 India |
Phone |
8747012060 |
Fax |
|
Email |
dinesh.upadhya@manipal.edu |
|
Details of Contact Person Public Query
|
Name |
Dr Dinesh Upadhya |
Designation |
Associate Professor and Coordinator |
Affiliation |
Manipal Academy of Higher Education |
Address |
Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104
Udupi KARNATAKA 576104 India |
Phone |
8747012060 |
Fax |
|
Email |
dinesh.upadhya@manipal.edu |
|
Source of Monetary or Material Support
|
Intramural grant to Dr. Dinesh Upadhya given by Manipal Academy of Higher Education, Manipal |
|
Primary Sponsor
|
Name |
Manipal Academy of Higher Education Intramural grant |
Address |
Kasturba Medical College Manipal Academy of Higher Education Madhav Nagar Manipal Udupi karnataka |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Dinesh Upadhya |
Kasturba Hospital |
Room No 1, 2nd floor,
Physiology Block
Department- Centre for Molecular Neurosciences
KMC Manipal Udupi KARNATAKA |
8747012060
dinesh.upadhya@manipal.edu |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Kasturba Medical College and Kasturba Hospital Institutional Ethics Commitee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: O369||Maternal care for fetal problem, unspecified, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
0.00 Day(s) |
Age To |
1.00 Day(s) |
Gender |
Both |
Details |
Preterm delivered just born fetus after parental consent will be included in the study
Groups with preterm birth with known maternal cause and unknown maternal cause of the fetus born preterm will be included |
|
ExclusionCriteria |
Details |
The parents who do not give consent would be excluded
The fetus who were delivered during the regular gestation period would be excluded |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
The study is expected to provide essential information about the magnitude of heavy metals in the cord blood of fetus born preterm due to unexplained as well as known maternal causes. |
Just born fetus(Day 0)upto 3 months for analysis.Cord blood from just born babies will be collected and analysed in the laboratory |
|
Secondary Outcome
|
Outcome |
TimePoints |
Effect of heavy metals in the developmental trajectories for upto one year |
From birth upto one year after delivery |
|
Target Sample Size
|
Total Sample Size="600" Sample Size from India="600"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
01/09/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NA |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
As per WHO 2019 data, globally, 15 million babies are born preterm every year and is the leading cause of death in children under the age of 5 years. India contributes one-fifth of global data with more than 3.5 million preterm birth per year (WHO, 2019). While less than 50% of the preterm birth is attributed to multiple maternal causes, more than 50% of cases are of unknown origin (Lawn et al., 2008; Blencowe et al., 2012). The risk of neonatal death due to complications of preterm birth is too high compared to term birth. Heavy metals such as mercury, cadmium, lead, arsenic, uranium, etc are well-known pollutants of the environment and could easily cross the placenta from maternal blood to reach the developing fetus (Gundacker and Hengstschläger, 2012). Heavy metals are well known to induce oxidative stress in the trophoblastic placental tissue (Singh et al., 2018). High levels of heavy metals were seen in maternal serum, resulting in multiple adverse birth outcomes (Kippler et al., 2012a, 2012b; Hu et al., 2016; Jiang et al., 2016; Yang et al., 2016; Sabra et al., 2017; Wai et al., 2017; Chen et al., 2018; Lin et al., 2018). High levels of heavy metals were also seen in maternal blood from the Indian population, resulting in adverse birth outcomes ( Awasthi et al., 2002). Heavy metals levels were seen in maternal and cord blood and placenta (Ong et al., 1993; Al saleh et al., 2011; Hu et al., 2015). We did not find any studies measuring the magnitude of multiple heavy metals in cord blood of babies born preterm. The proposed study is a prospective cohort study containing two experimental groups. In the first group, 200 babies born preterm due to unexplained causes will be taken. In the second group, 400 babies born preterm due to known maternal causes will be taken. Both the groups include all the preterm babies (below 28 weeks, 28-32 weeks, and 33-37 weeks) born at various gestational ages. Cord blood (10 ml) will be collected in a vacutainer from the umbilical cord and placenta after birth, the blood will be collected from the placental side and not from the fetal side and will be collected only after clamping. Written informed consent will be obtained from all participating mothers. Blood collected will be allowed to clot and centrifuged at 3000rpm for 15 minutes for serum collection. Serum samples will be aliquoted until analysis for heavy metals. All the heavy metals will be measured at Thyrocare Technologies Ltd, which measures several heavy metals such as lead, mercury, arsenic, cadmium, uranium, etc through inductively coupled plasma mass spectrometry (ICP-MS) method. All the preterm babies from both groups will be assessed until one year of development using Bayley Scales of Infant Development III for cognitive, motor, social-emotional, and adaptive behavior |